South and Central America Allergy Immunotherapies Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Country


No. of Pages: 78    |    Report Code: TIPRE00016214    |    Category: Life Sciences

South and Central America Allergy Immunotherapies Market
Buy Now

Market Introduction

Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.


Get more information on this report

South and Central America Allergy Immunotherapies Strategic Insights

Strategic insights for the South and Central America Allergy Immunotherapies provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-and-central-america-allergy-immunotherapies-market-strategic-framework.webp
Get more information on this report

South and Central America Allergy Immunotherapies Report Scope

Report Attribute Details
Market size in 2019 US$ 74.17 Million
Market Size by 2027 US$ 154.88 Million
Global CAGR (2019 - 2027) 9.7%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Treatment
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
By Allergy type
  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • HAL Allergy B.V.
  • ALK Abello A/S
  • Stallergenes Greer
  • Anergis
  • Circassia
  • Get more information on this report

    South and Central America Allergy Immunotherapies Regional Insights

    The geographic scope of the South and Central America Allergy Immunotherapies refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-and-central-america-allergy-immunotherapies-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The South and Central America Allergy immunotherapies market was valued at US$ 74.17 million in 2019 and is projected to reach US$ 154.88 million by 2027; it is expected to grow at a CAGR of 9.7% during the forecast period. The South and Central America allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies, restricted healthcare spending and regulatory variations across regions is likely to hamper the growth of the market during the forecast period.

    Key Market Segments

    The South and Central America Allergy immunotherapies market, based on treatment is segmented into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). In 2019, the Subcutaneous Immunotherapy (SCIT) segment held the largest share of the market, however, the Sublingual Immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period. Based on Allergy Type, the South and Central America allergy immunotherapies market was segmented into Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others. The Allergic Rhinitis segment held the highest share of the Allergy immunotherapies market in 2019. Moreover, the same segment is anticipated to witness growth at a significant rate during the forecast period.

    Based on distribution channel, the market is segmented into, hospital pharmacy, retail pharmacy and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market and the same pharmacy segment is expected to grow at the fastest rate during the forecast period.

     

     

     

     

    Major Sources and Companies Listed

    Some of the major primary and secondary sources for South and Central America allergy immunotherapies market included in the report are Celsion Corporation; World Allergy Organization (WAO), World Health Organization (WHO); Latin American Society of Allergy, Asthma, and Immunology (SLAAI); and Argentine Association of Allergy and Clinical Immunology (AAAeIC).

     

    Reasons to buy the report

    • Determine prospective investment areas based on a detailed trend analysis of the South and Central America allergy immunotherapy market over the next years.
    • Gain an in-depth understanding of the underlying factors driving demand for different South and Central America allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
    • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
    • Identify the major channels driving the South and Central America allergy immunotherapy market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
    • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America immunotherapy market.

     

    SOUTH AND CENTRAL AMERICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

    By Treatment

    • Subcutaneous Immunotherapy (SCIT)
    • Sublingual Immunotherapy (SLIT)

     

    By Allergy Type

    • Allergic Rhinitis
    • Asthma
    • Food Allergy
    • Venom Allergy
    • Others

    By Distribution Channel

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

    By Country

    • Brazil
    • Argentina
    • Rest of South and Central America

    Company Profiles

    • HAL Allergy B.V.
    • ALK Abello A/S
    • Stallergenes Greer
    • Anergis
    • Circassia

     

     

    The List of Companies - South and Central America Allergy Immunotherapies Market

    1. HAL Allergy B.V.
    2. ALK Abello A/S
    3. Stallergenes Greer
    4. Anergis
    5. Circassia

     

     

     

    Frequently Asked Questions
    How big is the South and Central America Allergy Immunotherapies Market?

    The South and Central America Allergy Immunotherapies Market is valued at US$ 74.17 Million in 2019, it is projected to reach US$ 154.88 Million by 2027.

    What is the CAGR for South and Central America Allergy Immunotherapies Market by (2019 - 2027)?

    As per our report South and Central America Allergy Immunotherapies Market, the market size is valued at US$ 74.17 Million in 2019, projecting it to reach US$ 154.88 Million by 2027. This translates to a CAGR of approximately 9.7% during the forecast period.

    What segments are covered in this report?

    The South and Central America Allergy Immunotherapies Market report typically cover these key segments-

    • Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy)
    • Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy)
    • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

    What is the historic period, base year, and forecast period taken for South and Central America Allergy Immunotherapies Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Allergy Immunotherapies Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Allergy Immunotherapies Market?

    The South and Central America Allergy Immunotherapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • HAL Allergy B.V.
  • ALK Abello A/S
  • Stallergenes Greer
  • Anergis
  • Circassia
  • Who should buy this report?

    The South and Central America Allergy Immunotherapies Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Allergy Immunotherapies Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now